Evaluation of a low‐dose desoxycorticosterone pivalate treatment protocol for long‐term management of dogs with primary hypoadrenocorticism

BACKGROUND: Lowering the dose of desoxycorticosterone pivalate (DOCP) for the treatment of dogs with primary hypoadrenocorticism (PH) decreases costs and could lead to increased owner motivation to treat their affected dogs. OBJECTIVE: To evaluate the efficacy of a low‐dose DOCP treatment protocol i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Vet Intern Med
Main Authors: Sieber‐Ruckstuhl, Nadia S., Reusch, Claudia E., Hofer‐Inteeworn, Nathalie, Kuemmerle‐Fraune, Claudia, Müller, Claudia, Hofmann‐Lehmann, Regina, Boretti, Felicitas S.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
SMALL ANIMAL
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524388/
https://ncbi.nlm.nih.gov/pubmed/30865322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.15475
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados